The University of New Mexico School of Medicine is a division of the University of New Mexico Health Sciences Center located in Albuquerque, New Mexico. The UNM School of Medicine is home to a variety of degree-granting programs, including the only MD program in the state.

During the past decade, University of New Mexico School of Medicine conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of New Mexico School of Medicine" #1 sponsor was "Children's Oncology Group" with 10 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 3 trials sponsored, "AM-Pharma" with 1 trials sponsored and "Actelion" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of New Mexico School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Becton, Dickinson and Company" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "University of New Mexico School of Medicine" are "HIV Infections" (4 trials), "Leukemia" (4 trials), "Brain Tumors" (3 trials), "Central Nervous System Tumors" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "University of New Mexico School of Medicine" in a lesser frequency.

Most popular intervention types in "University of New Mexico School of Medicine" are "Drug" (22 trials), "Biological" (7 trials), "Behavioral" (4 trials), "Radiation" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (7 trials), "vincristine sulfate" (6 trials), "Placebo" (4 trials), "cyclophosphamide" (4 trials) and "methotrexate" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of New Mexico School of Medicine" are 28 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of New Mexico School of Medicine". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in University of New Mexico School of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of New Mexico School of Medicine, 5 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".